Search

everythinglearnresearchcommunity

for

Search:↓

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Menopause can cause hair thinning and texture changes due to hormonal and metabolic shifts.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Salvianolic Acid B helps hair grow by reducing cell stress and increasing blood flow to hair follicles.

Insulin resistance may contribute to hair loss in people with androgenic alopecia.

Metformin is less effective in men with early-onset hair loss.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Combining minoxidil with dutasteride and microneedling is more effective for female pattern hair loss than just dutasteride and microneedling.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Estrogen therapy can reduce skin aging but has cancer risks.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Some African American women's central scalp hair loss is linked to genetics and past fungal scalp infections, with more research needed on other causes.

PRP shows promise for improving facial wrinkles, skin elasticity, and hair growth, but more research is needed to standardize its use and understand its effects.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Females have higher estrogen receptor levels in hair than males, and these levels decrease in white hair compared to black hair.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Prolactin affects hair growth cycles and can cause early hair follicle regression.